US Stock MarketDetailed Quotes

VCEL Vericel

Watchlist
  • 45.600
  • -0.650-1.41%
Close Aug 9 16:00 ET
  • 45.600
  • 0.0000.00%
Post 17:35 ET
2.24BMarket Cap4560.00P/E (TTM)

Vericel Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
Total revenue
14.68%52.66M
25.02%51.28M
20.17%197.52M
23.35%65M
18.24%45.58M
23.96%45.92M
13.70%41.02M
5.24%164.37M
10.72%52.69M
11.72%38.55M
Operating revenue
14.68%52.66M
25.02%51.28M
20.66%197.52M
23.35%65M
18.93%45.58M
24.70%45.92M
14.41%41.02M
6.94%163.7M
12.00%52.69M
13.67%38.33M
Cost of revenue
0.50%16.06M
9.86%15.93M
13.49%61.94M
14.15%16.49M
12.43%14.97M
12.61%15.98M
14.86%14.5M
8.81%54.58M
6.53%14.45M
7.33%13.32M
Gross profit
22.24%36.6M
33.31%35.35M
23.49%135.58M
26.82%48.51M
21.30%30.61M
31.01%29.94M
13.08%26.52M
3.55%109.79M
12.39%38.25M
14.19%25.23M
Operating expense
18.75%42.63M
17.64%40.82M
11.98%142.04M
11.23%35.78M
11.38%35.67M
12.42%35.9M
12.93%34.7M
11.39%126.85M
7.60%32.16M
18.34%32.02M
Selling and administrative expenses
15.07%35.27M
16.67%34.4M
13.18%121M
14.70%30.88M
11.17%29.99M
12.91%30.65M
14.00%29.49M
9.54%106.9M
3.67%26.92M
18.44%26.98M
Research and development costs
40.17%7.36M
23.14%6.42M
5.51%21.04M
-6.56%4.9M
12.49%5.68M
9.62%5.25M
7.24%5.21M
22.45%19.94M
33.66%5.25M
17.79%5.05M
Operating profit
-1.17%-6.03M
33.18%-5.46M
62.11%-6.46M
109.22%12.73M
25.50%-5.06M
34.36%-5.96M
-12.43%-8.18M
-117.19%-17.06M
46.95%6.09M
-36.83%-6.79M
Net non-operating interest income expense
43.45%1.36M
131.84%1.61M
313.54%4.03M
137.04%1.28M
369.20%1.11M
639.06%946K
891.43%694K
343.18%975K
800.00%540K
451.16%237K
Non-operating interest income
37.90%1.51M
110.01%1.76M
245.41%4.63M
88.20%1.44M
269.01%1.26M
639.86%1.1M
853.41%839K
498.66%1.34M
1,150.82%763K
677.27%342K
Non-operating interest expense
2.68%153K
5.52%153K
63.93%600K
-30.04%156K
42.86%150K
645.00%149K
705.56%145K
9,050.00%366K
22,200.00%223K
10,400.00%105K
Other net income (expense)
-60.00%-8K
41.67%-7K
-32.63%64K
2,833.33%82K
80.00%-1K
44.44%-5K
-110.71%-12K
82.69%95K
-137.50%-3K
61.54%-5K
Other non- operating income (expenses)
-60.00%-8K
41.67%-7K
-32.63%64K
2,833.33%82K
80.00%-1K
44.44%-5K
-110.71%-12K
82.69%95K
-137.50%-3K
61.54%-5K
Income before tax
6.73%-4.68M
48.47%-3.86M
85.19%-2.37M
112.82%14.09M
39.81%-3.95M
43.99%-5.02M
-5.70%-7.5M
-110.87%-15.99M
57.33%6.62M
-32.95%-6.56M
Income tax
12.90%814K
57.14%1.1M
-1,461.90%-286K
749.55%721K
314.72%700K
21K
Net income
6.73%-4.68M
48.47%-3.86M
80.96%-3.18M
119.40%12.99M
44.35%-3.66M
43.99%-5.02M
-5.70%-7.5M
-123.65%-16.71M
30.58%5.92M
-33.38%-6.58M
Net income continuous Operations
6.73%-4.68M
48.47%-3.86M
80.96%-3.18M
119.40%12.99M
44.35%-3.66M
43.99%-5.02M
-5.70%-7.5M
-123.65%-16.71M
30.58%5.92M
-33.38%-6.58M
Minority interest income
Net income attributable to the parent company
6.73%-4.68M
48.47%-3.86M
80.96%-3.18M
119.40%12.99M
44.35%-3.66M
43.99%-5.02M
-5.70%-7.5M
-123.65%-16.71M
30.58%5.92M
-33.38%-6.58M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
6.73%-4.68M
48.47%-3.86M
80.96%-3.18M
119.40%12.99M
44.35%-3.66M
43.99%-5.02M
-5.70%-7.5M
-123.65%-16.71M
30.58%5.92M
-33.38%-6.58M
Basic earnings per share
9.09%-0.1
50.00%-0.08
80.00%-0.07
107.69%0.27
42.86%-0.08
42.11%-0.11
-6.67%-0.16
-118.75%-0.35
30.00%0.13
-27.27%-0.14
Diluted earnings per share
9.09%-0.1
50.00%-0.08
80.00%-0.07
125.00%0.27
42.86%-0.08
42.11%-0.11
-6.67%-0.16
-118.75%-0.35
33.33%0.12
-27.27%-0.14
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
--
--
--
--
Unqualified Opinion
--
--
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022
Total revenue 14.68%52.66M25.02%51.28M20.17%197.52M23.35%65M18.24%45.58M23.96%45.92M13.70%41.02M5.24%164.37M10.72%52.69M11.72%38.55M
Operating revenue 14.68%52.66M25.02%51.28M20.66%197.52M23.35%65M18.93%45.58M24.70%45.92M14.41%41.02M6.94%163.7M12.00%52.69M13.67%38.33M
Cost of revenue 0.50%16.06M9.86%15.93M13.49%61.94M14.15%16.49M12.43%14.97M12.61%15.98M14.86%14.5M8.81%54.58M6.53%14.45M7.33%13.32M
Gross profit 22.24%36.6M33.31%35.35M23.49%135.58M26.82%48.51M21.30%30.61M31.01%29.94M13.08%26.52M3.55%109.79M12.39%38.25M14.19%25.23M
Operating expense 18.75%42.63M17.64%40.82M11.98%142.04M11.23%35.78M11.38%35.67M12.42%35.9M12.93%34.7M11.39%126.85M7.60%32.16M18.34%32.02M
Selling and administrative expenses 15.07%35.27M16.67%34.4M13.18%121M14.70%30.88M11.17%29.99M12.91%30.65M14.00%29.49M9.54%106.9M3.67%26.92M18.44%26.98M
Research and development costs 40.17%7.36M23.14%6.42M5.51%21.04M-6.56%4.9M12.49%5.68M9.62%5.25M7.24%5.21M22.45%19.94M33.66%5.25M17.79%5.05M
Operating profit -1.17%-6.03M33.18%-5.46M62.11%-6.46M109.22%12.73M25.50%-5.06M34.36%-5.96M-12.43%-8.18M-117.19%-17.06M46.95%6.09M-36.83%-6.79M
Net non-operating interest income expense 43.45%1.36M131.84%1.61M313.54%4.03M137.04%1.28M369.20%1.11M639.06%946K891.43%694K343.18%975K800.00%540K451.16%237K
Non-operating interest income 37.90%1.51M110.01%1.76M245.41%4.63M88.20%1.44M269.01%1.26M639.86%1.1M853.41%839K498.66%1.34M1,150.82%763K677.27%342K
Non-operating interest expense 2.68%153K5.52%153K63.93%600K-30.04%156K42.86%150K645.00%149K705.56%145K9,050.00%366K22,200.00%223K10,400.00%105K
Other net income (expense) -60.00%-8K41.67%-7K-32.63%64K2,833.33%82K80.00%-1K44.44%-5K-110.71%-12K82.69%95K-137.50%-3K61.54%-5K
Other non- operating income (expenses) -60.00%-8K41.67%-7K-32.63%64K2,833.33%82K80.00%-1K44.44%-5K-110.71%-12K82.69%95K-137.50%-3K61.54%-5K
Income before tax 6.73%-4.68M48.47%-3.86M85.19%-2.37M112.82%14.09M39.81%-3.95M43.99%-5.02M-5.70%-7.5M-110.87%-15.99M57.33%6.62M-32.95%-6.56M
Income tax 12.90%814K57.14%1.1M-1,461.90%-286K749.55%721K314.72%700K21K
Net income 6.73%-4.68M48.47%-3.86M80.96%-3.18M119.40%12.99M44.35%-3.66M43.99%-5.02M-5.70%-7.5M-123.65%-16.71M30.58%5.92M-33.38%-6.58M
Net income continuous Operations 6.73%-4.68M48.47%-3.86M80.96%-3.18M119.40%12.99M44.35%-3.66M43.99%-5.02M-5.70%-7.5M-123.65%-16.71M30.58%5.92M-33.38%-6.58M
Minority interest income
Net income attributable to the parent company 6.73%-4.68M48.47%-3.86M80.96%-3.18M119.40%12.99M44.35%-3.66M43.99%-5.02M-5.70%-7.5M-123.65%-16.71M30.58%5.92M-33.38%-6.58M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 6.73%-4.68M48.47%-3.86M80.96%-3.18M119.40%12.99M44.35%-3.66M43.99%-5.02M-5.70%-7.5M-123.65%-16.71M30.58%5.92M-33.38%-6.58M
Basic earnings per share 9.09%-0.150.00%-0.0880.00%-0.07107.69%0.2742.86%-0.0842.11%-0.11-6.67%-0.16-118.75%-0.3530.00%0.13-27.27%-0.14
Diluted earnings per share 9.09%-0.150.00%-0.0880.00%-0.07125.00%0.2742.86%-0.0842.11%-0.11-6.67%-0.16-118.75%-0.3533.33%0.12-27.27%-0.14
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --------------Unqualified Opinion----

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg
Concept CAR-T Therapy
CAR-T Therapy
Intraday-0.15%